INmune Bio, Inc.
INMB
$1.97
-$0.01-0.51%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 72.59% | -7.58% | -37.64% | 7.99% | 19.49% |
| Total Receivables | 52.19% | 0.50% | -0.77% | -58.39% | 26.88% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 143.96% | -37.46% | -62.34% | -13.23% | -10.51% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 71.92% | -7.51% | -36.79% | 1.00% | 19.01% |
|
|
|||||
| Total Current Assets | 71.92% | -7.51% | -36.79% | 1.00% | 19.01% |
| Net Property, Plant & Equipment | 288.49% | -9.45% | -8.36% | -7.71% | -6.68% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1,063.27% | -37.97% | -3.66% | 1.23% | -23.58% |
| Total Assets | -0.31% | -4.45% | -25.05% | 0.63% | 12.00% |
|
|
|||||
| Total Accounts Payable | 6.57% | 10.08% | -38.25% | 14.09% | -0.13% |
| Total Accrued Expenses | -- | -- | -54.55% | -60.43% | 148.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 50.68% | 4.29% | -94.67% | -48.54% | -32.60% |
| Total Finance Division Other Current Liabilities | -12.35% | 12.77% | -5.83% | 5.37% | 0.19% |
| Total Other Current Liabilities | -12.35% | 12.77% | -5.83% | 5.37% | 0.19% |
| Total Current Liabilities | 8.31% | 9.78% | -47.76% | -8.16% | -13.75% |
|
|
|||||
| Total Current Liabilities | 8.31% | 9.78% | -47.76% | -8.16% | -13.75% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 14.93% | -17.62% | -14.08% | -11.80% | -10.56% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.48% | 8.88% | -47.08% | -8.24% | -13.68% |
|
|
|||||
| Common Stock & APIC | 11.72% | 3.75% | 1.13% | 8.28% | 11.09% |
| Retained Earnings | -14.15% | -5.97% | -5.99% | -8.53% | -7.38% |
| Treasury Stock & Other | -25.08% | -6.09% | 44.50% | -45.30% | -6.58% |
| Total Common Equity | -2.72% | -7.55% | -17.01% | 6.60% | 28.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | 0.00% |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
|
|
|||||
| Total Common Equity | -2.72% | -7.55% | -17.01% | 6.60% | 28.55% |
| Total Preferred Equity | -- | -- | -- | -- | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.72% | -7.55% | -17.01% | 4.30% | 27.76% |
|
|
|||||